Graft vs Host Disease [clinicaltrials_resource:7f682d5b4b7018092ad4394feed1cb49]
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]clinicaltrials:NCT00001529Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00001561]Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia [clinicaltrials:NCT00001623]Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [clinicaltrials:NCT00001637]HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [clinicaltrials:NCT00001748]Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease [clinicaltrials:NCT00001872]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells [clinicaltrials:NCT00023491]Blood and Marrow Transplant Clinical Research Network [clinicaltrials:NCT00023530]clinicaltrials:NCT00025662Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease [clinicaltrials:NCT00032292]Study Evaluating Sirolimus (Rapamuneā¢) in Solid Organ Transplant Recipients [clinicaltrials:NCT00037531]Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients [clinicaltrials:NCT00044720]Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease [clinicaltrials:NCT00048789]Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related Stomatitis [clinicaltrials:NCT00075023]Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants [clinicaltrials:NCT00106925]clinicaltrials:NCT00117702Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease [clinicaltrials:NCT00136396]clinicaltrials:NCT00136903clinicaltrials:NCT00144430Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD) [clinicaltrials:NCT00146978]Study Evaluating Sirolimus in Kidney Transplant Recipients. [clinicaltrials:NCT00167947]Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant [clinicaltrials:NCT00179049]Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant [clinicaltrials:NCT00179075]High Dose Chemotherapy and Autologous Transplant for Breast Cancer [clinicaltrials:NCT00186641]Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease [clinicaltrials:NCT00186667]clinicaltrials:NCT00195273clinicaltrials:NCT00195429Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus [clinicaltrials:NCT00195468]Study Evaluating Sirolimus in Kidney Transplant Recipients in India [clinicaltrials:NCT00195481]Trial of Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00207792]clinicaltrials:NCT00224874GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease [clinicaltrials:NCT00228839]Theralux Extracorporeal Photochemotherapy (ECP) in Patients With Extensive Chronic Graft Versus Host Disease (GvHD) [clinicaltrials:NCT00248365]clinicaltrials:NCT00298324Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease [clinicaltrials:NCT00314483]A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease [clinicaltrials:NCT00350545]Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease [clinicaltrials:NCT00388362]
condition [clinicaltrials_vocabulary:condition]
T-Cell Depletion in Unrelated Donor Marrow Transplantation [clinicaltrials:NCT00000591]Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]clinicaltrials:NCT00001529Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00001561]Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia [clinicaltrials:NCT00001623]Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [clinicaltrials:NCT00001637]HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [clinicaltrials:NCT00001748]Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease [clinicaltrials:NCT00001872]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]clinicaltrials:NCT00002833Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003056]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]clinicaltrials:NCT00003335Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003398]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00003538]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003661]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [clinicaltrials:NCT00003662]Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant [clinicaltrials:NCT00003894]Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease [clinicaltrials:NCT00004194]Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004232]Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant [clinicaltrials:NCT00005852]Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [clinicaltrials:NCT00005988]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders [clinicaltrials:NCT00006056]Bone Marrow Transplantation in Treating Patients With Leukemia [clinicaltrials:NCT00006451]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma [clinicaltrials:NCT00006747]Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation [clinicaltrials:NCT00007059]Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon [clinicaltrials:NCT00010283]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells [clinicaltrials:NCT00023491]
condition browse [clinicaltrials_vocabulary:condition-browse]
T-Cell Depletion in Unrelated Donor Marrow Transplantation [clinicaltrials:NCT00000591]Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]clinicaltrials:NCT00001529Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [clinicaltrials:NCT00001561]Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia [clinicaltrials:NCT00001623]Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [clinicaltrials:NCT00001637]HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [clinicaltrials:NCT00001748]Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants [clinicaltrials:NCT00001830]Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease [clinicaltrials:NCT00001872]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]clinicaltrials:NCT00002833Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003056]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]clinicaltrials:NCT00003335Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003398]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00003538]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003661]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [clinicaltrials:NCT00003662]Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant [clinicaltrials:NCT00003894]Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease [clinicaltrials:NCT00004194]Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004232]Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00004878]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant [clinicaltrials:NCT00005852]Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy [clinicaltrials:NCT00005988]Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders [clinicaltrials:NCT00006056]Bone Marrow Transplantation in Treating Patients With Leukemia [clinicaltrials:NCT00006451]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma [clinicaltrials:NCT00006747]Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation [clinicaltrials:NCT00007059]Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon [clinicaltrials:NCT00010283]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer [clinicaltrials:NCT00014469]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells [clinicaltrials:NCT00023491]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Graft vs Host Disease [clinicaltrials_resource:7f682d5b4b7018092ad4394feed1cb49]
Bio2RDF identifier
7f682d5b4b7018092ad4394feed1cb49
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7f682d5b4b7018092ad4394feed1cb49
identifier
clinicaltrials_resource:7f682d5b4b7018092ad4394feed1cb49
title
Graft vs Host Disease
@en
type
label
Graft vs Host Disease [clinicaltrials_resource:7f682d5b4b7018092ad4394feed1cb49]
@en
Graft vs Host Disease